The company has received a licence from DRDO to manufacture and market "2-Deoxy-D-Glucose" (2-DG) as approved medication for the treatment of COVID-19 patients
2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.
2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's
Agni-5 to be mainstay of anti-China arsenal, Agni-P deterrent against Pakistan
The compressed air is expanded in a turbine so that refrigeration is produced.
Defence Minister Rajnath Singh has congratulated DRDO and the industry on the successful launch of rockets
The 2-DG is developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy' Laboratories.
In the absence of robust technological and project management structures, MoD's indigenisation drive will remain questionable
Uttarakhand Chief Minister Tirath Singh Rawat on Wednesday virtually inaugurated a 500-bed hospital set up for COVID-19 patients in Haldwani, the defence ministry said.
The new-generation platforms of the Indian Navy give it an edge in developing new AI technologies that are becoming increasingly popular with military and industry
The DRDO issued directions on the usage of its 2-DG drug on COVID-19 patients, stating that caution should be exercised while prescribing this medicine to people who have comorbidites
This technological breakthrough was achieved by the DRDO's premier metallurgical laboratory, the Hyderabad-based Defence Metallurgical Research Laboratory
The Defence Research and Development Organisation (DRDO) has developed the near isothermal forging technology used in manufacturing parts for aeroengines, the defence ministry said on Friday.
The drug will be provided to government hospitals at a discounted price, ANI quoted government officials as saying.
The kit can be used for sero-surveillance for detecting the presence of Covid antibodies amongst the population
DRL to manufacture oral drug, which reduces oxygen dependency in patients
The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said on Monday.
Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from Covid-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by DRDO
The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh
The first batch of 10,000 doses of 2DG medicine for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday